NCT06516302View on ClinicalTrials.gov

A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps

PHASE3RecruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

October 31, 2026

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

GR1802

GR1802 will be administered SC.

DRUG

Placebo

The placebo will be administered SC.

Trial Locations (1)

Unknown

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Genrix (Shanghai) Biopharmaceutical Co., Ltd.

INDUSTRY